Concepedia

Natasha Morse

NM

Statistics

Publications

8

Citations

1.5K

H-Index

8

Active since

1995

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Massachusetts General Hospital

Center for Cancer Research

Cornell University

Vall d'Hebron Institut de Recerca

Natasha Morse is an author at Memorial Sloan Kettering Cancer Center specializing in molecular oncology, signal transduction, and oncology.

Publications per year

1995–2016

8

Publications

8

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

Ana Bosch, Zhiqiang Li, Anna Bergamaschi et al. · Science Translational Medicine · 2015 · 436 citations

, , +17

mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in <i>PIK3CA</i> -Mutant Breast Cancer

Moshe Elkabets, Sadhna Vora, Dejan Juric et al. · Science Translational Medicine · 2013 · 347 citations · Full text

, , +17

AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas

Moshe Elkabets, Evangelos Pazarentzos, Dejan Juric et al. · Cancer Cell · 2015 · 340 citations · Full text

, , +17

Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

Jessica J. Tao, Pau Castel, Nina Radosevic‐Robin et al. · Science Signaling · 2014 · 166 citations

, , +16

Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating <i>PIK3CA</i> Alterations

Zachary S. Zumsteg, Natasha Morse, Gabriel Krigsfeld et al. · Clinical Cancer Research · 2015 · 78 citations · Full text

, , +14

1–5 of 8